Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Immunotherapy. Cedars-Sinai Medical Center, Los Angeles, CA, United States

Survival: 21.1 months
Toxicity Grade:
Treatments: Immunotherapy
Country: United States
City/State/Province: Los Angeles, CA
Hospital: Cedars-Sinai Medical Center
Journal: Link
Date: 7/2008

Patients: This phase 2 study involved 34 patients with glioblastoma multiforme. There were 10 women and 24 men, ranging in age from 22 to 74 years.

Treatment: Patients were treated with an immunotherapy, a vaccine against the tumor made from dendritic cells.

Toxicity: No toxicities associated with the treatment were reported.

Results: The median overall survival in patients that responded to the vaccine was 21.2 months (642 days), and 14.1 months (430) days in those that didnít respond (make a measureable immune response).

Support: This study was supported by research funds from MGI pharma, which developed the immunotherapy used in the study.

Correspondence: Dr. Christopher Wheeler

E-mail to a Friend Email Physician More Information